谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Chidamide Plus Envafolimab As Subsequent Treatment in Advanced Non‐small Cell Lung Cancer Patients Resistant to Anti‐pd‐1 Therapy: A Multicohort, Open‐label, Phase II Trial with Biomarker Analysis

Yaxiong Zhang, Zihong Chen,Yu Liu,Liang Han,Wei Jiang,Qiming Wang,Jianhua Shi, Liqin Lu,Jianying Li,Mingjun Zhang,Yan Huang,Yunpeng Yang,Xue Hou,Li Zhang,Jing Li,Wenfeng Fang,Gang Chen

Cancer Medicine（2024）

引用 2|浏览23
关键词
chidamide,envafolimab,non-small cell lung cancer,PD-1/PD-L1,resistant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要